Related Experiment Video
Updated: Jun 8, 2026
10:21
A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions
Published on: March 3, 2023
[Ovarian carcinoma: current diagnostic principles].
1Ustav patologie 1, LF UK a VFN, Praha. pdundr@seznam.cz
Ceskoslovenska Patologie
|October 15, 2010
Summary
Ovarian cancer, a leading cause of gynecologic cancer death, comprises heterogeneous neoplasms. Accurate histopathological diagnosis is crucial for advancing type-specific treatments and understanding genetic changes in ovarian carcinomas.
Area of Science:
- Gynecologic Oncology
- Pathology
- Molecular Biology
Context:
- Ovarian cancer is the leading cause of death from gynecologic cancers.
- Ovarian carcinomas are a heterogeneous group of neoplasms originating from surface epithelial-stromal cells.
- Tumors are broadly classified into Type I and Type II based on tumorigenesis pathways, exhibiting distinct behaviors and prognoses.
Purpose:
- To review recent advances in the histopathological diagnosis of ovarian carcinoma.
- To highlight the increasing importance of accurate diagnosis for type-specific treatment strategies.
- To discuss genetic alterations associated with different ovarian carcinoma subtypes.
Summary:
- Ovarian carcinomas are classified into Type I (low-grade, evolving from precursor lesions) and Type II (high-grade, de novo development).
- Type I includes low-grade serous/endometrioid adenocarcinoma, mucinous adenocarcinoma, and some clear cell carcinomas.
- Type II encompasses high-grade serous/endometrioid adenocarcinoma, undifferentiated carcinoma, malignant mixed Müllerian tumor, and some clear cell carcinomas.
Impact:
- Accurate histopathological diagnosis is essential for tailoring ovarian cancer treatments.
- Understanding the heterogeneity and genetic changes in ovarian carcinomas can lead to improved patient outcomes.
- Advances in diagnosis pave the way for personalized therapeutic approaches in ovarian cancer management.
